You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075%


✉ Email this page to a colleague

« Back to Dashboard


SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075%

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% potassium chloride; sodium chloride INJECTABLE;INJECTION 017648 NDA Baxter Healthcare Company 0338-0691-04 14 BAG in 1 CARTON (0338-0691-04) / 1000 mL in 1 BAG 1979-02-02
Baxter Hlthcare SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% potassium chloride; sodium chloride INJECTABLE;INJECTION 017648 NDA Baxter Healthcare Company 0338-0695-04 14 BAG in 1 CARTON (0338-0695-04) / 1000 mL in 1 BAG 1979-02-02
Baxter Hlthcare SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% potassium chloride; sodium chloride INJECTABLE;INJECTION 017648 NDA Baxter Healthcare Company 0338-0704-34 14 BAG in 1 CARTON (0338-0704-34) / 1000 mL in 1 BAG 1979-02-02
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drugs: Sodium Chloride 0.9% and Potassium Chloride 0.075%

Last updated: August 3, 2025


Introduction

Sodium chloride 0.9% (commonly known as normal saline) and potassium chloride 0.075% are essential electrolyte solutions widely used in medical settings. These solutions serve critical functions such as fluid resuscitation, electrolyte replenishment, and maintaining physiological stability in patients. The global demand underscores the importance of reliable suppliers capable of providing high-quality, regulatory-compliant products at scale. This article reviews primary manufacturers and suppliers globally, highlighting their market presence, certifications, and capacity to deliver these vital pharmaceutical solutions.


Market Overview

The global sterile saline and potassium chloride markets are driven by increasing healthcare infrastructure, rising prevalence of electrolyte imbalance disorders, and expanding outpatient care. As of 2023, key regions include North America, Europe, Asia-Pacific, and Latin America, with North America leading in supply capacity due to advanced manufacturing facilities and stringent regulatory standards.


Main Suppliers of Sodium Chloride 0.9%

1. Baxter International Inc.

Baxter is a dominant player in the production of sterile infusion solutions, including sodium chloride 0.9%. Their product portfolio features large-volume bags and small vials conforming to USP, EP, and other global standards. Baxter's extensive manufacturing facilities in the US, Europe, and Asia enable global distribution and supply reliability.

2. Pfizer Inc.

Pfizer manufactures and supplies saline solutions for both institutional and retail markets. Their pharmaceutical-grade saline solutions meet comprehensive regulatory requirements, with products distributed worldwide via regional distribution networks.

3. Hospira (now part of Pfizer)

Hospira specializes in injectable pharmaceuticals and infusion solutions, including sodium chloride 0.9%. Their products are ISO-certified and shipped globally, ensuring quality and consistency.

4. B. Braun Melsungen AG

A German-based healthcare giant, B. Braun offers a range of infusion and injection solutions, prominently including sodium chloride 0.9%. Their quality systems adhere strictly to EU GMP standards, with an extensive supply chain serving hospitals and clinics worldwide.

5. Fresenius Kabi

Fresenius supplies sterile saline solutions across various packaging formats. With manufacturing plants across Europe, the US, and Asia, they cater to a broad global market, emphasizing high-quality standards such as ISO 13485 and Good Manufacturing Practices (GMP).


Main Suppliers of Potassium Chloride 0.075%

1. Sigma-Aldrich (part of MilliporeSigma)

A leading supplier of pharmaceutical-grade chemicals, Sigma-Aldrich offers potassium chloride solutions suitable for injectable and infusion purposes. Their products meet rigorous pharmacopeial standards and are available globally.

2. Thermo Fisher Scientific

Thermo Fisher provides high-purity potassium chloride for pharmaceutical manufacturing, including prepared solutions at specified concentrations like 0.075%. Their manufacturing complies with ISO standards, serving research institutions and pharmaceutical companies.

3. Hospira / Pfizer

In addition to saline solutions, Pfizer/Hospira supply potassium chloride injections, ensuring regulatory compliance and reliable distribution channels.

4. Fagron

Fagron specializes in pharmaceutical compounding ingredients, including potassium chloride solutions. They serve compounding pharmacies and hospital pharmaceutical services with high-quality materials.

5. Chemoferm (part of Hianan Pharmaceutical)

This manufacturer supplies injectable-grade potassium chloride solutions, with certifications adhering to GMP and pharmacopeial standards, predominantly serving the Asian and European markets.


Regional Suppliers and Market Players

  • India:
    Indian pharmaceutical firms such as Hetero Drugs, Biocon, and Sun Pharma produce sodium chloride and potassium chloride solutions under strict regulatory oversight, serving both domestic and export markets.

  • China:
    Companies like Sino Biopharmaceutical and Hainan Pharmaceutical manufacture these solutions, with increasing GMP certifications aligning with global standards to meet rising demand.

  • Europe:
    Firms such as B. Braun, Fresenius Kabi, and Grifols maintain robust manufacturing bases, emphasizing compliance with the European Medicines Agency (EMA) guidelines.

  • North America:
    Major suppliers include Baxter, Pfizer, Hospira, and Fresenius Kabi, which hold extensive US Food and Drug Administration (FDA) approvals, ensuring high-quality standards.


Regulatory and Quality Considerations

Suppliers must adhere to multiple regulatory standards depending on the target market, including:

  • United States: FDA cGMP standards
  • European Union: EMA regulations and European Pharmacopoeia compliance
  • Japan: PMDA standards
  • China: NMPA (formerly CFDA) standards

Healthcare providers and pharmaceutical companies should verify the certification, batch records, and supply chain integrations when selecting suppliers, especially for sterile solutions requiring stringent validation processes.


Supply Chain and Reliability Factors

Reliability in supply is key amid global disruptions such as the COVID-19 pandemic, geopolitical issues, and raw material shortages. Leading suppliers maintain:

  • Multiple manufacturing sites to prevent regional shortages
  • Robust distribution networks ensuring timely delivery
  • Compliance with quality assurance protocols across the supply chain

Emerging players, especially in the Asia-Pacific region, are expanding capacity to meet forecasted growth, presenting additional sourcing options for international customers.


Conclusion

The selection of reliable suppliers for sodium chloride 0.9% and potassium chloride 0.075% hinges on quality certifications, regulatory compliance, manufacturing capacity, and supply chain robustness. Industry leaders such as Baxter, Pfizer, Fresenius Kabi, and B. Braun dominate global markets, while emerging suppliers in Asia strengthen regional options. Healthcare providers and pharmaceutical companies must conduct due diligence, including regulatory verification and quality audits, to ensure uninterrupted access to these essential solutions.


Key Takeaways

  • Major global suppliers include Baxter, Pfizer, Fresenius Kabi, Hospira, and B. Braun for sodium chloride 0.9%.
  • Potassium chloride 0.075% is supplied by Sigma-Aldrich, Thermo Fisher Scientific, and regional manufacturers meeting GMP standards.
  • Regulatory compliance and quality standards such as FDA, EMA, and ISO are essential for pharmaceutical-grade solutions.
  • Supply chain resilience is vital amid global disruptions; diversified sourcing strategies improve reliability.
  • Emerging Asian suppliers are expanding capacity, offering competitive options for procurement.

FAQs

1. Are all sodium chloride 0.9% solutions suitable for infusion therapy?
Yes, pharmaceutical-grade sodium chloride 0.9% solutions manufactured under GMP standards are suitable and widely used for infusion therapy across healthcare settings.

2. What certifications should I verify when sourcing potassium chloride 0.075%?
Ensure the product complies with pharmacopeial standards (e.g., USP, EP), has valid GMP certification, and complies with regional regulations such as FDA or EMA approvals.

3. How do regional regulations impact supplier selection?
Regulatory standards govern manufacturing practices, quality control, and product labeling. Suppliers adhering to recognized standards minimize compliance risks and ensure product safety.

4. Can regional suppliers meet global demand for these electrolyte solutions?
Leading regional suppliers in North America, Europe, and Asia have expanded manufacturing capacity, but supply consistency depends on regulatory approvals, raw material availability, and logistical factors.

5. What considerations are critical for importing these solutions internationally?
Importers must verify regulatory compliance in the destination country, ensure proper documentation, comply with customs procedures, and validate the quality certificates provided by suppliers.


Sources:

[1] Pharmacopoeia standards (USP, EP)
[2] Corporate websites: Baxter, Pfizer, Fresenius Kabi, B. Braun
[3] Industry reports on global infusion solutions market
[4] Regulatory agency guidelines (FDA, EMA, NMPA)
[5] Market analyses and supplier certifications

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.